Riskpilot← Back to searchSign inGet full accessInviocare Hellerup ApS
APSActiveCVR 37231304Heslehøj Alle 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20153 employeeswww.inviocare.com
Revenue 2024
DKK 1,6M
+2% vs 2023
EBITDA margin
-34.3%
+17% vs 2023
Equity ratio
-128.3%
Financial strength
Net profit 2024
DKK -620K
+23% vs 2023
| Revenue | DKK 1,6M | +2% |
| EBITDA | DKK -534K | +17% |
| Net profit | DKK -620K | +23% |
| Total assets | DKK 1,2M | -7% |
| Equity | DKK -1,5M | -69% |
| Employees | 3 | — |
Legal name
Inviocare Hellerup ApS
CVR number
37231304
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6. november 2015
Share capital
DKK 50.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er distribution af æstetiske produkter til det skandinaviske og tyske marked samt ejerskab og drift af klinikker inden for samme branche samt anden virksomhed, der efter direktionens skøn er forbundet dermed.
Address
Heslehøj Alle 4
Email
as@inviocare.com
Website
www.inviocare.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -896 | 328 | 3.114 | 2.674 | 1.261 | 7.066 | 2.703 | 2.408 | 1.531 | 1.559 |
| Staff expenses | -985 | -2.300 | -2.231 | -2.345 | -857 | -2.292 | -2.105 | -2.502 | -2.175 | -2.007 |
| EBITDA | -1.881 | -1.972 | 883 | 329 | 404 | 4.774 | 599 | -94 | -644 | -534 |
| Depreciation & amort. | -49 | -423 | -367 | -470 | -242 | -485 | -261 | -138 | -137 | -54 |
| EBIT | -1.930 | -2.395 | 516 | -142 | 161 | 4.289 | 338 | -233 | -781 | -588 |
| Net financials | -95 | -177 | -166 | -167 | -58 | -27 | -31 | -33 | -24 | -32 |
| Profit before tax | -2.024 | -2.572 | 350 | -309 | 104 | 4.262 | 308 | -265 | -805 | -620 |
| Tax | -0 | -0 | -0 | -0 | -0 | 1 | -0 | -0 | -0 | -0 |
| Net profit | -2.024 | -2.572 | 350 | -309 | 104 | 4.261 | 308 | -265 | -805 | -620 |
| Item | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.890 | 5.627 | 3.370 | 3.260 | 1.958 | 1.988 | 2.295 | 1.921 | 1.281 | 1.188 |
| Equity | -1.974 | -4.547 | -4.197 | -4.506 | -4.402 | -141 | 166 | -99 | -904 | -1.525 |
| Long-term debt | 0 | 0 | 0 | 0 | 31 | 1.108 | 1.000 | 1.000 | 1.000 | 2.284 |
| Short-term debt | 6.864 | 10.174 | 7.567 | 7.766 | 6.329 | 1.021 | 1.129 | 1.020 | 1.186 | 428 |
| Total debt | 6.864 | 10.174 | 7.567 | 7.766 | 6.361 | 2.129 | 2.129 | 2.020 | 2.186 | 2.713 |
EBITDA margin
-34.3%
This company
15.8%
Market median
-317% vs market
20162024
Equity ratio
-128.3%
This company
38.2%
Market median
-436% vs market
20162024
Return on equity
-62010500.0%
This company
18.4%
Market median
-337013687% vs market
20162024
Net profit margin
-39.8%
This company
8.1%
Market median
-591% vs market
20162024
Asset turnover
1.31×
This company
1.12×
Market median
+17% vs market
20162024
Debt / equity
1.78×
This company
0.62×
Market median
-187% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-07-01 – 2019-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-11-06 – 2016-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CH Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
LR Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
AG Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Anne Schow Holding ApS | Company | 100.0% | 100.0% | 2025 |
| Individual | 20.0% | 20.0% | 2021 | |
NMS Group A/S | Company | 100.0% | 100.0% | 2018 |
Ginnerup Capital ApS | Company | 15.0% | 15.0% | 2017 |
Fillerculture ApS | Company | 10.0% | 10.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Anne Schow Holding ApS
Inviocare Hellerup ApS Board members of Inviocare Hellerup ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Casper Henrique Tingkær | Chief Executive Officer | 0 companies |
| Louise Roth Rosendahl | Chief Executive Officer | 0 companies |
| Anne Ginnerup Schow | Chief Executive Officer | 0 companies |
| Christa Bormann | Board of Directors | 0 companies |
| Carsten Gunnar Olesen | Board of Directors | 0 companies |
| Monica Reib | Board of Directors | 0 companies |
| Kim Erik Ginnerup | Chairman | 0 companies |